| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Bate Kenneth is a Director at VNDA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 43 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 16,575 | $484.30 | $8,027,354.15 | -15.2% | +1.4% | - | |
| Aug 15, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 10,000 | $365.20 | $3,652,008.56 | -22.7% | +39.2% | - | |
| Feb 27, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $356.44 | $7,128,758.96 | -16.3% | -19.3% | +28.8% | |
| Apr 2, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 32,489 | $252.85 | $8,214,998.18 | -32.1% | +14.2% | +36.9% |